ScienceDex / Researcher record
Begale, Mark
- Vignet, Inc. (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 1% Funded
- Early Career
NIH Funding · FY2022
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2021 | $41,719,530 | 5 | #27 |
| 2022 | $46,891,131 | 5 | #28 |
| 2023 | $43,872,265 | 4 | #24 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20215 records
- FY2022 · selected5 records
- FY20234 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award records by amount
NIH award records listing Begale, Mark as a PI. Multi-PI records show the full award amount for context.
- $25.5Maward amount
- $10.1Maward amount
- $4.9Maward amount
- $4.5Maward amount
- $2Maward amount
Award organization
Organizations that administered FY2022 awards listing Begale, Mark as a PI.
FY2022 award administered by Vignet, Inc. (VA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardVignet, Inc.
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021$5M Cumulative Funding
- 2021$10M Cumulative Funding
- 2021$25M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #27
- 2021Entered Top 25% NationallyRanked #27
- 2021Entered Top 10% NationallyRanked #27
- 2021Entered Top 5% NationallyRanked #27
- 2021Entered Top 1% NationallyRanked #27
- 2022$50M Cumulative Funding
- 2023$100M Cumulative Funding